GMAB
GMAB
US3723032062
Genmab A/S
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.720.000.000 3.121.000.000
19.2%
Cost of Revenue 238.000.000 143.000.000
66.4%
Gross Profit 3.482.000.000 2.978.000.000
16.9%
2.232.000.000 1.963.000.000
13.7%
Operating Income 1.250.000.000 1.015.000.000
23.2%
Pretax Income 1.204.000.000 1.326.000.000
9.2%
Net Income Common Stockholders 963.000.000 1.133.000.000
15.0%
-- --
--
-- --
--
ende